IN2014CH01141A - - Google Patents

Download PDF

Info

Publication number
IN2014CH01141A
IN2014CH01141A IN1141CH2014A IN2014CH01141A IN 2014CH01141 A IN2014CH01141 A IN 2014CH01141A IN 1141CH2014 A IN1141CH2014 A IN 1141CH2014A IN 2014CH01141 A IN2014CH01141 A IN 2014CH01141A
Authority
IN
India
Prior art keywords
glucitol
anhydro
ethoxyphenyl
chloro
phenyl
Prior art date
Application number
Other languages
English (en)
Inventor
Thirumalai Rajan Srinivasan
Eswaraiah Sajja
Raghuram Suraparaju
Original Assignee
Msn Lab Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Msn Lab Private Ltd filed Critical Msn Lab Private Ltd
Priority to PCT/IN2015/000119 priority Critical patent/WO2015132803A2/fr
Priority to IN1141CH2014 priority patent/IN2014CH01141A/en
Priority to US15/303,577 priority patent/US20170029398A1/en
Priority to EP15758707.2A priority patent/EP3114115A4/fr
Publication of IN2014CH01141A publication Critical patent/IN2014CH01141A/en
Priority to US16/202,840 priority patent/US20190144411A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1141CH2014 2014-03-06 2015-03-06 IN2014CH01141A (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PCT/IN2015/000119 WO2015132803A2 (fr) 2014-03-06 2015-03-06 Procédé pour la préparation de (1s)-1,5-anhydro-1-c-[4-chloro-3-[(4-éthoxyphényl)méthyl]phényl]-d-glucitol et de son solvate
IN1141CH2014 IN2014CH01141A (fr) 2014-03-06 2015-03-06
US15/303,577 US20170029398A1 (en) 2014-03-06 2015-03-06 Process for the preparation of (1s)-1,5-anhydro-1-c-{4-chloro-3-4[(4-ethoxyphenyl)methyl]phenyl]-glucitol and its solvate thereof
EP15758707.2A EP3114115A4 (fr) 2014-03-06 2015-03-06 Procédé pour la préparation de (1s)-1,5-anhydro-1-c-[4-chloro-3-[(4-éthoxyphényl)méthyl]phényl]-d-glucitol et de son solvate
US16/202,840 US20190144411A1 (en) 2014-03-06 2018-11-28 Process for the preparation of (1S)-1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl) methyl]phenyl]-D-glucitol and its solvate thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1141CH2014 IN2014CH01141A (fr) 2014-03-06 2015-03-06

Publications (1)

Publication Number Publication Date
IN2014CH01141A true IN2014CH01141A (fr) 2015-09-11

Family

ID=54055961

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1141CH2014 IN2014CH01141A (fr) 2014-03-06 2015-03-06

Country Status (4)

Country Link
US (2) US20170029398A1 (fr)
EP (1) EP3114115A4 (fr)
IN (1) IN2014CH01141A (fr)
WO (1) WO2015132803A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106316803B (zh) * 2015-06-19 2019-07-09 重庆博腾制药科技股份有限公司 一种sglt-2抑制剂中间体的合成方法
ES2896101T3 (es) 2015-09-15 2022-02-23 Laurus Labs Ltd Cocristales de inhibidores de SGLT2, procedimiento para su preparación y composiciones farmacéuticas de los mismos
US9845303B2 (en) 2015-10-19 2017-12-19 Cadila Healthcare Limited Process for the preparation of dapagliflozin
WO2017130217A1 (fr) * 2016-01-27 2017-08-03 Msn Laboratories Private Limited Procédé de préparation de d-glucitol, 1,5- anhydro-1-c-[4-chloro-3-[[4-[[(3s)-tétrahydro-3-furanyl] oxy]phényl] méthyl]phényl]-, (1s) et ses formes cristallines
WO2017221211A1 (fr) * 2016-06-24 2017-12-28 Biocon Limited Procédé de préparation de dapagliflozine et de son solvate
CN107641139A (zh) * 2016-07-22 2018-01-30 江苏豪森药业集团有限公司 达格列净中间体的晶型及其制备方法
CN108610316B (zh) * 2016-12-09 2021-11-05 江苏豪森药业集团有限公司 达格列净的制备方法
WO2018142422A1 (fr) * 2017-02-02 2018-08-09 Indoco Remedies Limited Procédé de préparation de dapagliflozine
CN107417515A (zh) * 2017-03-30 2017-12-01 上海常丰生物医药科技有限公司 一种合成达格列净中间体的新方法
CN109705075B (zh) * 2018-12-13 2022-12-23 苏中药业集团股份有限公司 一种达格列净的纯化方法
CN110396040B (zh) * 2019-09-09 2020-12-15 东南大学 一种一锅法合成二芳基甲缩酮的方法
WO2021176096A1 (fr) 2020-03-05 2021-09-10 Krka, D.D., Novo Mesto Composition pharmaceutique comprenant un inhibiteur du sglt2
CN115867538A (zh) 2020-06-05 2023-03-28 新梅斯托克公司 高纯的无定形达格列净的制备
CN111748004A (zh) * 2020-06-30 2020-10-09 药璞(上海)医药科技有限公司 一种高纯度达格列净中间体的晶型及其制备方法
CN112500267A (zh) 2020-12-04 2021-03-16 江苏慧聚药业有限公司 4-溴-2-(4’-乙氧基-苄基)-1-氯苯的制备
CN113880796A (zh) * 2021-10-14 2022-01-04 山东诚创蓝海医药科技有限公司 一种达格列净的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515117B2 (en) * 1999-10-12 2003-02-04 Bristol-Myers Squibb Company C-aryl glucoside SGLT2 inhibitors and method
PH12000002657B1 (en) * 1999-10-12 2006-02-21 Bristol Myers Squibb Co C-aryl glucoside SGLT2 inhibitors
AU2003299966A1 (en) * 2003-01-03 2004-08-10 Bristol-Myers Squibb Company Methods of producing c-aryl glucoside sglt2 inhibitors
US7919598B2 (en) * 2006-06-28 2011-04-05 Bristol-Myers Squibb Company Crystal structures of SGLT2 inhibitors and processes for preparing same
WO2012173410A2 (fr) * 2011-06-14 2012-12-20 Green Cross Corporation Nouveaux inhibiteurs c-aryle ansa de sglt2
BR112014010574A2 (pt) * 2011-10-31 2017-05-02 Scinopharm Taiwan Ltd formas cristalinas e não cristalinas de inibidores sglt2
WO2015104658A2 (fr) * 2014-01-08 2015-07-16 Dr. Reddy’S Laboratories Limited Dispersion solide amorphe de dapagliflozine et procédé pour la préparation de dapagliflozine amorphe

Also Published As

Publication number Publication date
US20190144411A1 (en) 2019-05-16
WO2015132803A2 (fr) 2015-09-11
WO2015132803A3 (fr) 2016-01-14
EP3114115A2 (fr) 2017-01-11
EP3114115A4 (fr) 2017-08-23
US20170029398A1 (en) 2017-02-02

Similar Documents

Publication Publication Date Title
WO2015132803A3 (fr) Procédé pour la préparation de (1s)-1,5-anhydro-1-c-[4-chloro-3-[(4-éthoxyphényl)méthyl]phényl]-d-glucitol et de son solvate
PH12017500408B1 (en) Heteroaryl compounds as btk inhibitors and uses thereof
LT3230278T (lt) Nauji metilpiperidino junginiai, naudingi mikrosomalinės prostaglandino e2 sintazės-1 slopinimui
EP3209653A4 (fr) Procédé de préparation de (r,s)-nicotine
EP3227610B8 (fr) Paroi réfractaire, en particulier pour four à combustion
IN2014CH00247A (fr)
EA201691649A1 (ru) Способ получения противогрибковых соединений
EP3137074A4 (fr) Antagonistes du récepteur ep2 des prostaglandines, dérivés, compositions et utilisations associés
EA201691648A1 (ru) Способ получения противогрибковых соединений
EP3102554A4 (fr) Conversion de 2, 3-butanediol en butadiène
MX2017002214A (es) Proceso para la preparacion de 5-fluoro-1h-pirazoles partiendo de hexafluoropropeno.
IL250038A0 (en) 4,5 - dehydroisoxazole derivatives used as nampt inhibitors
CL2017000152A1 (es) Derivados de isoindolinona
EA201790982A1 (ru) Синтез копанлисиба и его дигидрохлорида
MA40313A (fr) Composition pharmaceutique à base d'isotrétinoïne destinée à la voie orale
HK1249046A1 (zh) 治疗b型肝炎病毒的方法
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
CL2017000151A1 (es) Derivados de piridona
HK1221645A1 (zh) Vmat2的苯并喹啉抑制剂
IN2014MU01192A (fr)
MA40447A (fr) Composition pharmaceutique orale d'isotrétinoïne
MA40312A (fr) Composition pharmaceutique orale d'isotrétinoïne
IN2014MU00195A (fr)
IN2014CH00304A (fr)
EP3102540A4 (fr) Compositions comprenant un nanocomposite de zno à lacunes artificielles (ve), procédés de fabrication et d'utilisation d'une composition